NCT02163356 Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma Status TERMINATED Phase PHASE1
NCT02159443 Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody Status COMPLETED Phase N/A
NCT02130869 A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT02107963 A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors Status COMPLETED Phase PHASE1
NCT02100930 Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma Status COMPLETED Phase NA
NCT02100891 Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors Status TERMINATED Phase PHASE2
NCT02076906 MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT02075177 Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02035137 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat Status COMPLETED Phase PHASE2
NCT02030964 N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan Status COMPLETED Phase PHASE1
NCT02013336 Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors Status UNKNOWN Phase PHASE1
NCT01987596 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Status TERMINATED Phase PHASE3
NCT01962103 Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01953900 iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01943097 Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma Status UNKNOWN Phase N/A
NCT01916187 Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma Status WITHDRAWN Phase PHASE1